Teladoc Health Inc (NYSE:TDOC) shares are trading higher Monday. The company announced that its predictive AI-modeling led to increased engagement among diabetes members, driving additional A1c reduction.

What Happened: Teladoc Health has released new data from two studies presented at the American Diabetes Association's 84th Scientific Sessions. The studies show that Teladoc's predictive modeling capabilities can help members with type 2 diabetes control their blood sugar through participation in the company's diabetes management program.

The new data showed a 3x increase in engagement, which led to an additional 0.4 reduction in A1c for members targeted with personalized health notifications after being identified as at-risk for uncontrolled diabetes by AI. Teladoc said members experienced a reduction from 8.2% to 7.8%.

Teladoc also noted that diabetes members that received personalized next-best actions in their weekly email were 50% more likely to engage with a health coach.

"Teladoc Health has a long-standing history of successfully using data to improve health outcomes for our members, and new applications of AI are helping us accelerate our impact," said Sal Shafiq, chief data and analytics officer at Teladoc Health.

"Our ability to use data to empower members in the moment is crucial, but the true power lies in our ability to predict health risks and make prevention a reality."

The results follow previous research from Teladoc, demonstrating the company's ability to use AI to identify a person at-risk for uncontrolled outcomes more than a year in advance.

Don't Miss: Altimmune Stock Is Rising Monday: What's Driving The Action?

TDOC Price Action: Teladoc shares were up 10.5% at $10.73 at the time of writing, according to data from Benzinga Pro.

Photo: courtesy of Teladoc.